| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,675,000 | 3,731,000 | 3,554,000 | 4,370,000 | | Cost of Revenue | 2,144,000 | 2,165,000 | 2,104,000 | 2,642,000 | | | Gross Profit | 1,531,000 | 1,566,000 | 1,450,000 | 1,728,000 | | | Operating Expenses | | Research Development | 209,000 | 202,000 | 204,000 | 212,000 | | Selling General and Administrative | 1,099,000 | 1,170,000 | 1,031,000 | 1,883,000 | | Non Recurring | (2,000) | (1,000) | (2,000) | (467,000) | | Others |
-
| (14,000) | 14,000 | 54,000 | | | | Total Operating Expenses |
-
| 1,357,000 | 1,247,000 | 1,682,000 | | | | Operating Income or Loss | 225,000 | 209,000 | 203,000 | 46,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (5,000) | 5,000 | 18,000 | | Earnings Before Interest And Taxes | 225,000 | 204,000 | 208,000 | 64,000 | | Interest Expense | 67,000 | 7,000 | 130,000 | 143,000 | | Income Before Tax | 158,000 | 197,000 | 78,000 | (79,000) | | Income Tax Expense | 44,000 | 59,000 | 19,000 | (59,000) | | Minority Interest |
-
| 7,000 | (7,000) | (92,000) | | | | Net Income From Continuing Ops | 129,000 | 154,000 | 42,000 | 1,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 129,000 | 154,000 | 42,000 | 1,000 | | Preferred Stock And Other Adjustments | (6,000) | (14,000) |
-
|
-
| | | Net Income Applicable To Common Shares | $123,000 | $140,000 | $42,000 | $1,000 |
|
0.11% Nasdaq 0.00%
Income Statement
